Like cartographers completing a map, investigators have identified multiple new subtypes of the most common childhood cancer—research that will likely improve the diagnosis and treatment of high-risk patients. St. Jude ...
Jan 14, 2019
0
25
The nervous and immune systems have long been thought to be separate entities in the body, but new research has uncovered a direct cellular interaction between the two. Scientists from Harvard Medical School, the Broad Institute ...
Dec 17, 2020
0
93
Autism affects at least 2% of children in the United States—an estimated 1 in 59. This is challenging for both the patients and their parents or caregivers. What's worse is that today there is no medical treatment for autism. ...
May 20, 2019
0
25
Stem cells create new nerve cells in the brain over the entire life span. One of the places this happens is the hippocampus, a region of the brain that plays a significant role in many learning processes. A reduction in the ...
Dec 21, 2020
0
70
The University of Liege announces that it has developed an automated test for the detection of SARS-CoV-2, the virus responsible for Covid-19. The technique developed at ULiege allows to increase the daily capacity of detection ...
Apr 6, 2020
0
3
In cancer research, it's a common goal to find something about cancer cells—some sort of molecule—that drives their ability to survive, and determine if that molecule could be inhibited with a drug, halting tumor growth. ...
Jul 2, 2021
0
20
Results from a pivotal trial of PRO 140, a new HIV therapy, show that PRO 140 is an effective, long-acting therapeutic in combination with antiretroviral treatment (ART) for previously treated HIV-1 infected patients. This ...
Jun 9, 2018
0
4
Currently, there is no cure for amyotrophic lateral sclerosis (ALS). Things could soon change, however. Researchers at FAU and the University of California San Diego (UCSD) have identified a protein that already displays ...
Jul 19, 2022
0
78
The coronavirus pandemic brought global renown to the mRNA technology that underpins vaccines from Pfizer/BioNTech and Moderna, and on Monday earned a Nobel Prize for two scientists who have been key to its development.
Oct 2, 2023
0
80
A new, multicenter study led by Fred Hutchinson Cancer Research Center and Memorial Sloan Kettering Cancer Center determined how a single mutation in splicing factor 3b subunit 1 (SF3B1), the most frequently mutated splicing ...
Oct 9, 2019
0
35
